Literature DB >> 6334490

Comparative penetration of cefonicid and cefazolin into the atrial appendage and pericardial fluid of patients undergoing open-heart surgery.

M N Dudley, C H Nightingale, A D Drezner, H B Low, R Quintiliani.   

Abstract

The penetration of cefonicid and cefazolin into cardiac tissue was compared after a single 30-mg/kg dose in 30 patients undergoing aortocoronary artery bypass graft surgery. Samples of the right atrial appendage, pericardial fluid, and serum were obtained at various times and assayed for drug content. The concentrations of cefonicid in serum and the atrial appendage were at least twice those observed for cefazolin at a given time after a dose. The mean (+/- standard deviation) atrial appendage-serum ratio was 0.47 +/- 0.14 for cefonicid and 0.34 +/- 0.06 for cefazolin (P less than 0.005). Pericardial fluid concentrations of cefonicid were slightly lower than those observed in patients receiving cefazolin (P greater than 0.05). A single intravenous dose of cefonicid provides high and sustained concentrations in serum and cardiac tissue and thus may be useful in antibiotic prophylaxis of certain surgical procedures; however, further study of the efficacy of this agent in the prevention and treatment of infections associated with Staphylococcus spp. is needed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6334490      PMCID: PMC176167          DOI: 10.1128/AAC.26.3.347

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  Sources of contamination in open heart surgery.

Authors:  R M Kluge; F M Calia; J S McLaughlin; R B Hornick
Journal:  JAMA       Date:  1974-12-04       Impact factor: 56.272

2.  Penetration of antibiotics into fibrin loci in vivo. 3. Intermittent vs. continuous infusion and the effect of probenecid.

Authors:  M Barza; J Brusch; M G Bergeron; L Weinstein
Journal:  J Infect Dis       Date:  1974-01       Impact factor: 5.226

3.  Antibiotic prophylaxis and cardiac surgery. A prospective double-blind comparison of single-dose versus multiple-dose regimens.

Authors:  J E Conte; S N Cohen; B B Roe; R M Elashoff
Journal:  Ann Intern Med       Date:  1972-06       Impact factor: 25.391

Review 4.  Antibiotic prophylaxis in surgical procedures. A critical analysis of the literature.

Authors:  B J Guglielmo; D C Hohn; P J Koo; T K Hunt; R L Sweet; J E Conte
Journal:  Arch Surg       Date:  1983-08

5.  Antimicrobial prophylaxis: a critique of recent trials.

Authors:  J V Hirschmann; T S Inui
Journal:  Rev Infect Dis       Date:  1980 Jan-Feb

6.  Cefonicid concentrations in serum and atrial tissue during open-heart surgery.

Authors:  R P Sterling; D J Connor; J C Norman; D A Cooley
Journal:  Antimicrob Agents Chemother       Date:  1983-05       Impact factor: 5.191

Review 7.  First and second generation cephalosporins.

Authors:  R Quintiliani; M French; C H Nightingale
Journal:  Med Clin North Am       Date:  1982-01       Impact factor: 5.456

8.  Antimicrobial prophylaxis in surgery: part 2.

Authors:  J T DiPiro; K E Record; K S Schanzenbach; B A Bivins
Journal:  Am J Hosp Pharm       Date:  1981-04

9.  Cephalothin prophylaxis in cardiac valve surgery. A prospective, double-blind comparison of two-day and six-day regimens.

Authors:  D A Goldmann; C C Hopkins; A W Karchmer; R M Abel; M T McEnany; C Akins; M J Buckley; R C Moellering
Journal:  J Thorac Cardiovasc Surg       Date:  1977-03       Impact factor: 5.209

10.  Antibiotic levels in pericardial fluid.

Authors:  J S Tan; J C Holmes; N O Fowler; G T Manitsas; J P Phair
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

View more
  8 in total

1.  In vitro pharmacodynamics of vancomycin and cefazolin alone and in combination against methicillin-resistant Staphylococcus aureus.

Authors:  Mao Hagihara; Dora E Wiskirchen; Joseph L Kuti; David P Nicolau
Journal:  Antimicrob Agents Chemother       Date:  2011-10-17       Impact factor: 5.191

2.  Impact of Intraoperative Cell Salvage on Concentrations of Antibiotics Used for Surgical Prophylaxis.

Authors:  Maxwell J Lasko; Allison M Conelius; Oscar K Serrano; David P Nicolau; Joseph L Kuti
Journal:  Antimicrob Agents Chemother       Date:  2020-11-17       Impact factor: 5.191

3.  Pharmacokinetics of cefazolin prophylaxis in obese gravidae at time of cesarean delivery.

Authors:  Omar M Young; Imam H Shaik; Roxanna Twedt; Anna Binstock; Andrew D Althouse; Raman Venkataramanan; Hyagriv N Simhan; Harold C Wiesenfeld; Steve N Caritis
Journal:  Am J Obstet Gynecol       Date:  2015-06-20       Impact factor: 8.661

Review 4.  Considerations in dosage selection for third generation cephalosporins.

Authors:  J H Yuk-Choi; C H Nightingale; T W Williams
Journal:  Clin Pharmacokinet       Date:  1992-02       Impact factor: 6.447

5.  Tissue pharmacokinetics of cefazolin in patients with lower limb infections.

Authors:  Amira A Bhalodi; Seth T Housman; Ashley Shepard; James Nugent; David P Nicolau
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

Review 6.  Cefonicid. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  E Saltiel; R N Brogden
Journal:  Drugs       Date:  1986-09       Impact factor: 9.546

7.  Pharmacokinetics and tissue concentrations of cefazolin in pediatric patients undergoing gastrointestinal surgery.

Authors:  M C Nahata; D E Durrell; M E Ginn-Pease; D R King
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1991 Jan-Mar       Impact factor: 2.441

8.  Population Pharmacokinetics of Cefazolin in Serum and Tissue for Patients with Complicated Skin and Soft Tissue Infections (cSSTI).

Authors:  Wonhee So; Joseph L Kuti; David P Nicolau
Journal:  Infect Dis Ther       Date:  2014-11-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.